Suggested Readings

Immune monitoring post liver transplant.

Sood S, Testro AG. World J Transplant. 2014;4(1):30-39.

Immunosuppressive drug therapy.

Hartono C, et al. Cold Spring Harb Perspect Med. 2013;3(9):a015487.

Calcineurin inhibitor–free mycophenolate mofetil/sirolimus maintenance in liver transplantation: the randomized Spare-the-Nephron Trial.

Teperman L, et al. Liver Transpl. 2013;19:675-689.

Are calcineurin inhibitors-free regimens ready for prime time?

Vincenti F. Kidney Int. 2012;82(10):1054-1060.

TOR signaling in growth and metabolism.

Wullschleger S, et al. Cell. 2006;124(3):471-484.

Review of the proliferation inhibitor everolimus.

Nashan B. Expert Opin Investig Drugs. 2002;11(12):1845-1857.

Sirolimus: its discovery, biological properties, and mechanism of action.

Sehgal SN. Transplant Proc. 2003;35(suppl 3):7S-14S.

Identifying biomarkers as diagnostic tools in kidney transplantation.

Mas VR, et al. Expert Rev Mol Diagn. 2011;11(2):183-196.

Urinary-cell mRNA profile and acute cellular rejection in kidney allografts.

Suthanthiran M, et al. N Engl J Med. 2013;369(1):20-31.

Linked Resources

Management Guidelines

2012 Practice Guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation

KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients, 2009

General Resources

American Society of Transplantation

The American Society of Transplantation was founded in 1982 and is an organization of more than 3000 professionals dedicated to advancing the field of transplantation and improving patient care by promoting research, education, advocacy, and organ donation.

The Transplantation Society

The Transplantation Society is a Non-Governmental Organization (NGO) which serves as an international forum for the world-wide advancement of organ transplantation. 

The National Kidney Foundation

The National Kidney Foundation is the leading organization in the U.S. dedicated to the awareness, prevention and treatment of kidney disease for hundreds of thousands of healthcare professionals, millions of patients and their families, and tens of millions of Americans at risk.

American Liver Foundation

The American Liver Foundation was created in 1976 by the American Association for the Study of Liver Disease (AASLD) to facilitate, advocate and promote education, support and research for the prevention, treatment and cure of liver disease.

Related activities
1.00 AMA PRA

Advances in Immunosuppressive Therapy for Solid Organ Transplantation

Long-term Management Strategies to Improve Patient Outcomes

Faculty: Simin Goral, MD; Manikkam Suthanthiran, MD; Lewis W. Teperman, MD
Release: 12/19/2014
Expiration: 12/19/2015